← All trials
NCT05246618
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2022
- Primary completion
- Mar 3, 2023
- Completion date
- Mar 3, 2023
- First posted
- Feb 18, 2022
- Last posted
- Apr 12, 2022
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- iCoat Medical ABLead sponsor
- Region SkaneCollaborator
- Clinical Trial Consultants ABCollaborator
- iCoat Medical ABStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.